Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Expert Rev Clin Pharmacol. 2019 May;12(5):471–479. doi: 10.1080/17512433.2019.1597705

Table 1.

Benefits, potential uses, cautions, and side effects of recently FDA-approved insulins.

Insulin Type Benefits Potential Use Cautions Side Effects
Insulin Human Inhalation Powder [19] Rapid on, rapid off mitigate postprandial hyperglycemia Hyperglycemia correction, prandial insulin dosing, patients with lipodystrophy or needle phobia Spirometry (FEV1) prior to use, then every 6–12 months, contraindicated in chronic lung disease & active lung cancer, caution use in those who smoke, severe hypoglycemia Bronchospasm, hypoglycemia, throat pain/irritation
Fast-acting insulin aspart [11,12,13] Rapid on, rapid off Hyperglycemia correction, prandial insulin dosing, may be given within 20 minutes of the start of a meal Severe hypoglycemia Hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, weight gain
Glargine U300 [25] Duration of action > 24 hours, can be given at any time during the day rather than the same time each day Patients who have difficulty remembering to take insulin at the same time each day Titrate dose no more frequently than every 3–4 days to minimize risk of hypoglycemia, a higher daily dose may be needed than Glargine U100 insulin Hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, pruritis, rash edema, weight gain
Degludec [30] Duration of action > 24 hours, can be given at any time during the day rather than the same time each day, pediatric patients Patients who have difficulty remembering to take insulin at the same time each day, those needing greater than 80 units of basal insulin each day (up to 160 units in a single dose), those who experience pain with insulin injections (physiologic pH) Titrate doses no more frequently than every 3–4 days to minimize risk of hypoglycemia, doses should be given no less than 8 hours apart, no conversion needed between U100 and U200 insulins Hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, pruritis, rash, edema, weight gain